New Arguments in favor of the Release Active Antiviral Drug to Prepare Children for Vaccination
Main Authors: | V. P. Vavilova, A. M. Vavilov, A. H. Chercaeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Diagnostics and Vaccines"
2015-12-01
|
Series: | Детские инфекции (Москва) |
Subjects: | |
Online Access: | https://detinf.elpub.ru/jour/article/view/180 |
Similar Items
-
Prevention of Pneumococcal Infection in Children with Chronic Diseases of the Nasopharynx Reduces the Incidence of Other Respiratory Tract Infections: Results of a Comparative Prospective Study
by: V. P. Vavilova, et al.
Published: (2015-11-01) -
Experience of Vaccination of a Patient with Systemic Juvenile Idiopathic Arthritis (sJIA) with a 13-Valent Pneumococcal Conjugate Vaccine, prior to the Appointment of Therapy with Tocilizumab, an Anti-IL-6-Receptor Monoclonal Antibody
by: Daria D. Vankova, et al.
Published: (2018-10-01) -
13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: Clinical Case
by: Ekaterina I. Alekseeva, et al.
Published: (2019-09-01) -
The effectiveness of immunization of children against Pneumococcal infection in Penza, Russia
by: O. N. Lesina, et al.
Published: (2019-04-01) -
NASOPHARYNGEAL CARRIAGE OF STREPTOCOCCUS PNEUMONIAE IN ORPHANS, PRESCHOOL CHILDREN AND UNORGANIZED CHILDREN UNDER 5 YEARS
by: M. A. Lazareva, et al.
Published: (2015-04-01)